Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease

Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386

A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation

Erel, Ö. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.015 · Cited by 2,940

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

Nau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,063

Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease

Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 767

Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target

Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498

Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women

Wang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496

p-Cresyl Sulfate

Gryp, T., Vanholder, R. C., Vaneechoutte, M., & Glorieux, G. (2017) · Toxins · doi:10.3390/toxins9020052 · Cited by 427

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193

A gut-derived metabolite alters brain activity and anxiety behaviour in mice

Needham, B. D., Funabashi, M., Adame, M. D., Wang, Z., Boktor, J. C., Haney, J., Wu, W.-L., Rabut, C., Ladinsky, M. S., Hwang, S.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-04396-8 · Cited by 489

Microbiota-derived metabolites as drivers of gut–brain communication

Ahmed, H., Leyrolle, Q., Koistinen, V., Kärkkäinen, O., Layé, S., Delzenne, N., & Hanhineva, K. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2102878 · Cited by 462

The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic

Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392

Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

Shao, Y., Li, T., Liu, Z., Wang, X., Xu, X., Li, S., Xu, G., & Le, W. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00425-8 · Cited by 226

The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease

Tran, S. M.-S., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu13030732 · Cited by 213

Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208

Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics

Tan, A. H., Chong, C. W., Lim, S., Yap, I. K. S., Teh, C. S. J., Loke, M. F., Song, S., Tan, J. Y., Ang, B. H., Tan, Y. Q., et al. (2021) · Annals of Neurology · doi:10.1002/ana.25982 · Cited by 196

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 212

Implications of Gut Microbiota in Neurodegenerative Diseases

Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., & Cheng, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785644 · Cited by 161

Boundaries and integration between microbiota, the nervous system, and immunity

Macpherson, A. J., Pachnis, V., & Prinz, M. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.011 · Cited by 118

The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders

Praveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 116

Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

Liabeuf, S., Pépin, M., Franssen, C. F. M., Viggiano, D., Carriazo, S. M., Gansevoort, R. T., Gesualdo, L., Hafez, G., Małyszko, J., Mayer, C. C., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab223 · Cited by 120

Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma

Ntranos, A., Park, H.-J., Wentling, M., Tolstikov, V., Amatruda, M., Inbar, B., Kim‐Schulze, S., Frazier, C., Button, J., Kiebish, M. A., et al. (2021) · Brain · doi:10.1093/brain/awab320 · Cited by 108

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism

Fitzgerald, K. C., Smith, M. D., Kim, S., Sotirchos, E. S., Kornberg, M. D., Douglas, M., Nourbakhsh, B., Graves, J., Rattan, R., Poisson, L., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100424 · Cited by 102

p-Cresol Sulfate Caused Behavior Disorders and Neurodegeneration in Mice with Unilateral Nephrectomy Involving Oxidative Stress and Neuroinflammation

Sun, C., Li, J., Wang, Y., Lin, S., Ou, Y., Lin, C., Wang, J., Liao, S., & Chen, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186687 · Cited by 100

Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson’s disease

Paul, K. C., Zhang, K., Walker, D. I., Sinsheimer, J. S., Yu, Y., Kusters, C., Rosario, I. D., Folle, A. D., Keener, A. M., Bronstein, J. M., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00694-5 · Cited by 94

The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases

Zhou, Y., Zhang, Y., Jin, S., Lv, J., Li, M., & Feng, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117031 · Cited by 94

Indoxyl sulfate caused behavioral abnormality and neurodegeneration in mice with unilateral nephrectomy

Sun, C., Li, J., Wang, Y., Lin, S., Ou, Y., Lin, C., Wang, J., Liao, S., & Chen, C. (2021) · Aging · doi:10.18632/aging.202523 · Cited by 79

Gut Microbiota-Derived Metabolite Trimethylamine N-Oxide as a Biomarker in Early Parkinson’s Disease

Chung, S. J., Rim, J. H., Ji, D., Lee, S., Yoo, H. S., Jung, J. H., Baik, K., Choi, Y., Ye, B. S., Sohn, Y. H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111090 · Cited by 74

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis

Chen, S., & Lin, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00839-6 · Cited by 85

Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disorders

Mudimela, S., Vishwanath, N. K., Pillai, A., Morales, R., Marrelli, S. P., Barichello, T., & Giridharan, V. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.08.002 · Cited by 71

The Gut Metabolite Trimethylamine N‐oxide Is Associated With Parkinson's Disease Severity and Progression

Chen, S., Kuo, C., Kuo, H., Chen, C., Wu, W., Liou, J., Wu, M., & Lin, C. (2020) · Movement Disorders · doi:10.1002/mds.28246 · Cited by 65

Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide

Loo, R. L., Chan, Q. M., Nicholson, J. K., & Holmes, E. C. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00851 · Cited by 63

The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders

Marzal, L. N. P., Prince, N., Bajić, D., Roussin, L., Naudon, L., Rabot, S., Garssen, J., Kraneveld, A. D., & Perez‐Pardo, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810052 · Cited by 67

The Role of Bacterial-Derived Aromatic Amino Acids Metabolites Relevant in Autism Spectrum Disorders: A Comprehensive Review

Zheng, Y., Bek, M. K., Prince, N., Marzal, L. N. P., Garssen, J., Perez‐Pardo, P., & Kraneveld, A. D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.738220 · Cited by 59

Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease

Quan, W., Qiao, C.-M., Niu, G.-Y., Wu, J., Zhao, L.-P., Cui, C., Zhao, W.-J., & Shen, Y.-Q. (2023) · Brain Sciences · doi:10.3390/brainsci13050790 · Cited by 49

Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO

Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47

Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease

Watanabe, K., Sato, E., Mishima, E., Watanabe, M., Abe, T., Takahashi, N., & Nakayama, M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06221 · Cited by 43

Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson’s Disease Model Mice

Qiao, C.-M., Quan, W., Zhou, Y., Niu, G.-Y., Hong, H., Wu, J., Zhao, L.-P., Li, T., Cui, C., Zhao, W.-J., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03392-x · Cited by 45

Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease

Denman, C. R., Park, S. M., & Jo, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1268419 · Cited by 45

The metabolite p ‐cresol impairs dendritic development, synaptogenesis, and synapse function in hippocampal neurons: Implications for autism spectrum disorder

Guzmán‐Salas, S., Weber, A., Malci, A., Lin, X., Herrera‐Molina, R., Cerpa, W. F., Dorador, C., Signorelli, J. R., & Zamorano, P. L. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15604 · Cited by 40

The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson’s Disease Patients

Plewa, S., Popławska-Domaszewicz, K., Florczak‐Wyspianska, J., Klupczyńska-Gabryszak, A., Sokół, B., Miltyk, W., Jankowski, R., Kozubski, W. P., Kokot, Z. J., & Matysiak, J. (2021) · Pharmaceuticals · doi:10.3390/ph14090935 · Cited by 35

Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment

Kalecký, K., & Bottiglieri, T. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00531-y · Cited by 32

Clostridioides difficile infection dysregulates brain dopamine metabolism

Vinithakumari, A. A., Padhi, P., Hernandez, B., Lin, S. J.-H., Dunkerson-Kurzhumov, A., Showman, L., Breitzman, M., Stokes, C., Sulaiman, Y., Tangudu, C., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00073-22 · Cited by 31

The Autism Spectrum Disorder-Associated Bacterial Metabolite p-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10

Zheng, Y., Prince, N., Marzal, L. N. P., Ahmed, S., Garssen, J., Perez‐Pardo, P., & Kraneveld, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911013 · Cited by 30

Plasma metabolites of aromatic amino acids associate with clinical severity and gut microbiota of Parkinson’s disease

Chen, S., Wu, Y., Chen, C., Wu, Y., Liou, J., Wu, M., Kuo, C., & Lin, C. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00612-y · Cited by 28

The relationship between Parkinson’s disease and gastrointestinal diseases

Zeng, J., Wang, X., Pan, F., & Mao, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.955919 · Cited by 26

Review of Elevated Para-Cresol in Autism and Possible Impact on Symptoms

Flynn, C. K., Adams, J. B., Krajmalnik‐Brown, R., Khoruts, A., Sadowsky, M. J., Nirmalkar, K., Takyi, E., & Whiteley, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041513 · Cited by 25

Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury

Pristner, M., Wasinger, D., Seki, D., Klebermaß-Schrehof, K., Berger, A., Berry, D., Wisgrill, L., & Warth, B. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101480 · Cited by 20

Causal effect of gut‐microbiota‐derived metabolite trimethylamine N‐oxide on Parkinson's disease: A Mendelian randomization study

Zhou, H., Luo, Y., Zhang, W., Xie, F., Deng, C., Zheng, W., Zhu, S., & Wang, Q. (2023) · European Journal of Neurology · doi:10.1111/ene.15702 · Cited by 22

Neuroinflammation in kidney disease and dialysis

Chagas, Y. E. W., de Castro, P. A. S. V., & Silva, A. C. S. E. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115465 · Cited by 19

Relationship between Excreted Uremic Toxins and Degree of Disorder of Children with ASD

Osredkar, J., Gantar, B. Ž. B., Finderle, P., Bobrowska‐Korczak, B., Gątarek, P., Rosiak, A., Giebułtowicz, J., Vrhovšek, M. J., & Kałużna‐Czaplińska, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087078 · Cited by 19

Elevation of Gut-Derived p-Cresol During Spaceflight and its Effect on Drug Metabolism and Performance in AstronautsPreprint

Schmidt, M. A., Meydan, C., Schmidt, C. M., Afshinnekoo, E., & Mason, C. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.10.374645 · Cited by 19

Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study

Janeiro, M. H., Solas, M., Orbe, J., Rodríguez, J. A., de Muniain, L. S., Escalada, P., Yip, P. K., & Ramírez, M. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417557 · Cited by 20

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice

Morais, L. H., Boktor, J. C., MahmoudianDehkordi, S., Kaddurah‐Daouk, R., & Mazmanian, S. K. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00816-w · Cited by 24

Assessment of trimethylamine-N-oxide at the blood-cerebrospinal fluid barrier: Results from 290 lumbar punctures

Enko, D., Zelzer, S., Niedrist, T., Holasek, S. J., Baranyi, A., Schnedl, W. J., Herrmann, M., & Meinitzer, A. (2020) · EXCLI journal · doi:10.17179/excli2020-2763 · Cited by 17

Comparative plasma metabolomic analysis to identify biomarkers for lead-induced cognitive impairment

Wang, Y., Nong, Y., Zhang, X., Mai, T., Cai, J., Liu, J., Lai, K. P., & Zhang, Z. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110143 · Cited by 17

TMAO promotes dementia progression by mediating the PI3K/Akt/mTOR pathway

Hu, X., Zhang, Y., Gu, C., Gu, C., Yao, Y., Yao, Y., Luo, L., & Zhang, Y. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102034 · Cited by 20

Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons

Liu, J., Ge, P., Luo, Y., Sun, Z., Luo, X., Li, H., Pei, B., Xun, L., Zhang, X., Jiang, Y., et al. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s512207 · Cited by 20

High levels of Bifidobacteriaceae are associated with the pathogenesis of Parkinson’s disease

Zuo, S., Wang, H., Zhao, Q., Tang, J., Wang, M., Zhang, Y., Sang, M., Tian, J., & Wang, P. (2023) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.1054627 · Cited by 16

DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson’s disease

Zhao, Y., Shen, W., Zhang, M., Guo, M., Dou, Y., Han, S., Yu, J., Cui, M., & Zhao, Y. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06772-w · Cited by 15

Trimethylamine-N-oxide aggravated the sympathetic excitation in D-galactose induced aging rats by down-regulating P2Y12 receptor in microglia

Wang, P., Mi, Y., Yu, H. N., Teng, X., Jin, S., Xiao, L., Xue, H., Tian, D., Guo, Q., & Wu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116549 · Cited by 15

Effects of p-Cresol on Senescence, Survival, Inflammation, and Odontoblast Differentiation in Canine Dental Pulp Stem Cells

Zayed, M., & Iohara, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186931 · Cited by 13

A metabolomics study in aqueous humor discloses altered arginine metabolism in Parkinson’s disease

Serrano‐Marín, J., Marín, S., Bernal‐Casas, D., Lillo, A., González‐Subías, M., Navarro, G., Cascante, M., Sánchez-Navés, J., & Franco, R. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00494-5 · Cited by 13

Determination of Trimethylamine N-oxide and Betaine in Serum and Food by Targeted Metabonomics

He, M., Yu, H., Peng, L., Huang, S., Ren, J., Fan, W., Han, L., Yu, H., Wang, Y., Ren, M. Q., et al. (2021) · Molecules · doi:10.3390/molecules26051334 · Cited by 13

Implications of Gut Microbiota-Derived Metabolites in Neurological Disorders

Dalal, N., Jaiswal, J., Kushwaha, M., Verma, H., Rana, P., Gupta, S., Panwar, R., Janmeda, P., Jain, P., Singh, A. K., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00414 · Cited by 12

Integrative Metabolome and Proteome Analysis of Cerebrospinal Fluid in Parkinson’s Disease

Kim, S. G., Hwang, J. S., George, N. P., Jang, Y. E., Kwon, M., Lee, S. S., & Lee, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111406 · Cited by 12

Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review

Saija, C., Currò, M., Ientile, R., Caccamo, D., & Bertuccio, M. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083672 · Cited by 11

LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients

Gątarek, P., Kałużna‐Czaplińska, J., Pawelczyk, M., Jastrzębski, K., Giebułtowicz, J., Glabinski, A. R., & Bobrowska‐Korczak, B. (2020) · Molecules · doi:10.3390/molecules25214959 · Cited by 11

Gut microbiota and Parkinson’s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective

Jin, X., Wei, J., Min, X., Fan, Y., Yuan, Z., Du, Z., Su, Z., Xun, T., Du, Q., Liang, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114185 · Cited by 15

Indoxyl Sulfate and Autism Spectrum Disorder: A Literature Review

Hill, Z. R., Flynn, C. K., & Adams, J. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312973 · Cited by 11

CuO nanoparticles adorned anodic WO3 nanosheets: Facile synthesis and electrochemical sensing of tyrosine biomarker

Ghazi, R., Ali, G., Cho, S. O., Al‐Zaqri, N., & Rehman, Z. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141980 · Cited by 10

The interaction between intestinal bacterial metabolites and phosphatase and tensin homolog in autism spectrum disorder

Zheng, Y., Prince, N., van Hattem, C., Garssen, J., Perez‐Pardo, P., & Kraneveld, A. D. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103805 · Cited by 10

Gut microbiota dysbiosis and neurologic diseases: New Horizon with potential diagnostic and therapeutic impact

Keshavarzian, A., & Sisodia, S. S. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00478 · Cited by 12

Trimethylamine-N-oxide damages astrocytes and lymphatic endothelial cells in the cerebral lymphatic system

Su, M., Duan, H.-S., Wang, Q.-L., Zhang, Y., Shi, X.-M., Zeng, J., Tan, W.-N., Chang, Y., & Wang, S. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.09.001 · Cited by 8

Para-Cresol and the Brain: Emerging Role in Neurodevelopmental and Neurodegenerative Disorders and Therapeutic Perspectives

Bertarini, L., Imbeni, F., Brighenti, V., Martusciello, I., Pellati, F., & Alboni, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00289 · Cited by 8

Enrichment of gut-derived metabolites in a Parkinson’s disease subtype with REM sleep behavior disorder

Lee, S., Kim, J. H., Baek, J. W., Jung, K.-Y., Lee, Y., Koh, A., & Kim, H. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01040-w · Cited by 10

Plasma Metabolomics Profiles in Prodromal and Clinical Parkinson's Disease

Flores‐Torres, M. H., Peng, X., Jeanfavre, S., Clish, C. B., Wang, Y., McCullough, M. L., Healy, B. C., Schwarzschild, M. A., Bjørnevik, K., & Ascherio, A. (2025) · Movement Disorders · doi:10.1002/mds.30308 · Cited by 7

The role of neuroimmune and inflammation in pediatric uremia-induced neuropathy

Zhu, L., Tong, G., Yang, F., Zhao, Y., & Chen, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013562 · Cited by 7

Small phenolic and indolic gut-dependent molecules in the primate central nervous system: levels vs. bioactivity

Jaskiw, G. E., Xu, D., Obrenovich, M. E., & Donskey, C. J. (2022) · Metabolomics · doi:10.1007/s11306-021-01866-4 · Cited by 7

Circulatory dietary and gut-derived metabolites predict early cognitive decline

Connell, E., Sami, S. A. K., Khondoker, M. R., Minihane, A. M., Pontifex, M. G., Müller, M. M., McArthur, S., Gall, G. L., & Vauzour, D. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2649487 · Cited by 6

The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review

Meng, S. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111775 · Cited by 6

The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease

Vališ, M., Dlabková, A., Hort, J., Angelucci, F., Pejchal, J., Kuča, K., Pavelek, Z., Karasová, J. Ž., & Novotný, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114223 · Cited by 5

Total analysis system for the determination of uremic toxins in human plasma based on bead injection solid phase extraction hyphenated to mass spectrometry

Fernandes, S. R., Barreiros, L., Sampaio‐Maia, B., Miró, M., & Segundo, M. A. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341668 · Cited by 4

Gut Microbes in Parkinson's Disease

Markidi, A., Elford, J. D., Berkers, C. R., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00002-3 · Cited by 4

Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model

Polyák, H., Galla, Z., Rajda, C., Monostori, P. B., Klivènyi, P., & Vécsei, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030976 · Cited by 4

β-Cyclodextrin with Sodium Alginate based Nanosponges Preparation and Characterization in the Removal of Organic Toxin: p-Cresol in the Simulated Biological Fluids

Azeez, S. A., Sultana, A., & Hajera, A. (2022) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2022.00045 · Cited by 4

Circulatory dietary and gut-derived metabolites predict preclinical Alzheimer’s diseasePreprint

Connell, E., Sami, S. A. K., Khondoker, M. R., Minihane, A. M., Pontifex, M. G., Müller, M. M., McArthur, S., Gall, G. L., & Vauzour, D. (2024) · medRxiv · doi:10.1101/2024.05.10.24307050 · Cited by 4

Higher p-Cresol sulfate and tumor necrosis factor (TNF)-α levels are associated with cognitive improvement through increased TNF receptor 2 in individuals with mild cognitive impairment: A cross-sectional mediation analysis

Azargoonjahromi, A., Nasiri, H., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251362483 · Cited by 3

Communication Theoretical Analysis of P-Cresol Signaling in Gut-Brain Axis with Autism Spectrum Disorder

Ortlek, B. E., & Akan, Ö. B. (2023) · International Conference on Communications · doi:10.1109/icc45041.2023.10279237 · Cited by 5

Expansion of a versatile pathogen: Clostridioides difficile

Lucas, T., & Brown, B. (2024) · Hygiene and Environmental Health Advances · doi:10.1016/j.heha.2024.100108 · Cited by 2

Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2

Immunology and microbiome: Implications for motor systems

Mahjoub, Y., & Martino, D. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00001-7 · Cited by 2

Mendelian randomization analysis of the causal relationship between trimethylamine N oxide and its precursors and Parkinson’s disease

Zhang, B., Zhang, R., Ren, H., Guan, Q., Fan, W., & Han, L. (2024) · Archives of Medical Science · doi:10.5114/aoms/184128 · Cited by 2

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersPreprint

Lee, S., Kim, J. H., Baek, J., Jung, K., Lee, Y., Koh, A., & Kim, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.02.592293 · Cited by 2

Extracorporeal hemoadsorption and neurological disorders: A challenging perspective

Ramírez‐Guerrero, G., Ferri-Cortés, A., Cabrera-Aguilar, J. S., & Ronco, C. (2025) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-25-00015 · Cited by 1

Therapeutic potential of phytochemicals and role of gut microbiota in neurodegenerative diseases

Gupta, S. K., & Sharma, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36372-6.00014-8 · Cited by 1

The gut–brain axis and trimethylamine N-oxide: an emergent biomarker in neurological diseases

Arangia, A., Paola, R. D., Cuzzocrea, S., Siracusa, R., D’Amico, R., & Impellizzeri, D. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.05.005 · Cited by 1

Parkinson’s disease and inflammatory bowel disease: exploring the connection between the two

Zhou, X., Zhang, X., Liang, H., & Bi, Y. (2026) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2026.01 · Cited by 1

The microbiome: what a neurologist needs to know

Dehghanizai, A. B., Stewart, C. J., & Thomas, R. H. (2025) · Practical Neurology · doi:10.1136/pn-2024-004400 · Cited by 1

Age-related microbiome metabolites alter RNA splicing and chromatin accessibility in the brainPreprint

Chakraborty, M., Shi, S. M., Porter, I. E., Richard, D. J., Marinov, G. K., Murthy, M. N., Moore, A. A., Blum, J. L. E., Natarajan, A., Jahng, J. W. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680371 · Cited by 2

Cuantificación del p-cresol sérico y su relación con la masa muscular en pacientes en hemodiálisis

Rojas, M., & Ximena, M. (2020)

Trimethylamine N-Oxide levels increase in patients with severe and non-severe COVID-19

Yasak, İ. H., Yılmaz, M., Ceylan, M. R., Koyuncu, İ., & ŞEYHANLI, E. S. (2023) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21403

#5438 SERUM TUMOUR NECROSIS FACTOR RECEPTOR 1 PROTEIN ACCURATELY PREDICTS RAPID DISEASE PROGRESSION IN DIABETIC KIDNEY DISEASE

Bidin, M. Z., Shah, A. M., Stanslas, J., Ghani, F. B. A., Goh, B. L., & Lim, C. T. S. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad063c_5438

Full Validation and Application to Clinical Research of a High-Performance Liquid Chromatography Method for the Assessment of Urinary 3-Indoxyl Sulfate in Pediatric Patients with Hematopoietic Stem Cell Transplant

Olivetti, C. E., Fernández, M. F., Stojanova, J., Ruvinsky, S., Mangano, A. M., & Schaiquevich, P. S. (2024) · Methods and Protocols · doi:10.3390/mps7040064

Research Progress on the Relationship between Gut Microbiome and Parkinson’s Disease

力比奴尔·塞地尔丁, 克. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14123217

Dual flow-path HPLC method for time-optimised quantification of physicochemically different metabolite classes in human serum samples using a single mass spectrometer

Faist, C., Tacke, E., Eierhoff, T., Oberhuber, A., & Hayen, H. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.466636

Additional file 1 of Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

Shao, Y., Li, T., Liu, Z., Wang, X., Xu, X., Li, S., Xu, G., & Le, W. (2021) · Figshare · doi:10.6084/m9.figshare.13634334

Additional file 1 of A metabolomics study in aqueous humor discloses altered arginine metabolism in Parkinson’s disease

Serrano‐Marín, J., Marín, S., Bernal‐Casas, D., Lillo, A., González-Subías, M., Navarro, G., Cascante, M., Sánchez-Navés, J., & Franco, R. (2023) · Figshare · doi:10.6084/m9.figshare.24741892

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00369 · Cited by 85

NITRITE AND MALONDIALDEHYDE CONTENT IN CEREBROSPINAL FLUID OF PATIENTS WITH PARKINSON’S DISEASE

Shukla, R., RAJANI, M., SRIVASTAVA, N., Barthwal, M. K., & Dikshit, M. (2006) · International Journal of Neuroscience · doi:10.1080/00207450500513989 · Cited by 40

Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease

Björkhem, I., Lövgren‐Sandblom, A., Leoni, V., Meaney, S., Brodin, L., Salveson, L., Winge, K., Pålhagen, S., & Svenningsson, P. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.003 · Cited by 112

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease

Heilman, P. L., Wang, E. W., Lewis, M. M., Krzyżanowski, S., Capan, C. D., Burmeister, A. R., Du, G., Galvis, M. L. E., Brundin, P., Huang, X., et al. (2020) · Movement Disorders · doi:10.1002/mds.28202 · Cited by 134

Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy

Takahashi, K., Iwaoka, K., Takahashi, K., Suzuki, Y., Taguchi, K., Yamahara, K., & Maeda, T. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135975 · Cited by 12